Phyllis A. Dennery

Phyllis A. Dennery

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
BKBalaraman Kalyanaraman
Balaraman Kalyanaraman
VDVictor Darley-Usmar
Victor Darley-Usmar
KDKelvin J.A. Davies
Kelvin J.A. Davies
PDPhyllis A. Dennery
Phyllis A. Dennery
HFHenry Forman
Henry Forman
HIHarry Ischiropoulos
Harry Ischiropoulos

22 February 2001 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDPhyllis A. Dennery
Phyllis A. Dennery
DSDaniel S. Seidman
Daniel S. Seidman
DSDavid K. Stevenson
David K. Stevenson
Icterus neonatorum, or neonatal jaundice, has long been recognized.1 The term “kernicterus” was introduced in the early 1900s to refer to the yellow staining of the basal ganglia observed in infants who died with severe jaundice.2 From the 1950s through the 1970s, because of a high incidence of Rh hemolytic disease and kernicterus, pediatricians were aggressive in treating jaundice.3 However, several factors have changed the management of jaundice. Studies in the 1980s and 1990s suggested that kernicterus from jaundice was rare and that too many infants were being treated unnecessarily.47 Also, newborn infants were being discharged from the hospital . . .

1 October 1997 in Photochemistry and Photobiology
Verified
Journal Article
Closed access
PDF file
CCChristopher Contag
Christopher Contag
SSStanley D. Spilman
Stanley D. Spilman
PCPamela R. Contag
Pamela R. Contag
MOMasafumi Oshiro
Masafumi Oshiro
BEBrian Eames
Brian Eames
DBDavid A. Benaron
David A. Benaron

1 September 2007 in Birth Defects Research Part C: Embryo Today: Reviews
Verified
Journal Article
Closed access
PDF file
PDPhyllis A. Dennery
Phyllis A. Dennery

1 July 2007 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
QLQing Lin
Qing Lin
SWSebastian Weis
Sebastian Weis
GYGuang Yang
Guang Yang
YWYi-Hao Weng
Yi-Hao Weng
RHRachel Helston
Rachel Helston
PDPhyllis A. Dennery
Phyllis A. Dennery
Heme oxygenase-1 (HO-1), the rate-limiting enzyme in heme degradation, is an integral membrane protein of the smooth endoplasmic reticulum. However, we detected an HO-1 immunoreactive signal in the nucleus of cultured cells after exposure to hypoxia and heme or heme/hemopexin. Under these conditions, a faster migrating HO-1 immunoreactive band was enriched in nuclear extracts, suggesting that HO-1 was cleaved to allow nuclear entry. This was confirmed by the absence of immunoreactive signal with an antibody against the C terminus and the lack of a C-terminal sequence by gas chromatographymass spectrometry. Incubation with leptomycin B prior to hypoxia abolished nuclear HO-1 and the faster migrating band on Western analysis, suggesting that this process was facilitated by CRM1. Furthermore, preincubation with a cysteine protease inhibitor prevented nuclear entry of green fluorescent protein-labeled HO-1, demonstrating that protease-mediated C-terminal cleavage was also necessary for nuclear transport of HO-1. Nuclear localization was also associated with reduction of HO activity. HO-1 protein, whether it was enzymatically active or not, mediated activation of oxidant-responsive transcription factors, including activator protein-1. Nevertheless, nuclear HO-1 protected cells against hydrogen peroxide-mediated injury equally as well as cytoplasmic HO-1. We speculate that nuclear localization of HO-1 protein may serve to up-regulate genes that promote cytoprotection against oxidative stress.

1 January 2015 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
HFHenry Forman
Henry Forman
OAOhara Augusto
Ohara Augusto
RBRegina Brigelius-Flohe
Regina Brigelius-Flohe
PDPhyllis A. Dennery
Phyllis A. Dennery
BKBalaraman Kalyanaraman
Balaraman Kalyanaraman
KDKelvin J.A. Davies
Kelvin J.A. Davies